2019
DOI: 10.1002/ange.201903140
|View full text |Cite
|
Sign up to set email alerts
|

Protecting‐Group‐Controlled Enzymatic Glycosylation of Oligo‐N‐Acetyllactosamine Derivatives

Abstract: Supportinginformation and the ORCID identification number(s) for the author(s) of this article can be found under: https://doi.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…So far, only two known approaches have recently been developed for the site‐specific enzymatic fucosylation of oligo‐LacNAc glycans. In 2019, Boons and co‐workers reported a protecting‐group controlled site‐specific enzymatic fucosylation strategy (Scheme 1a, i), [18] in which a chemically synthesized tri‐LacNAc hexasaccharide with orthogonal protected amine groups was used as the common substrate for site‐specific enzymatic fucosylation. The lacotosamine units containing either free amine or tert ‐butyloxycarbonyl (Boc) protecting group are not tolerated by both human and bacterial α1,3‐fucosyltransferases, thus the α1,3‐fucosylation could only take place at the intact LacNAc unit [18] .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…So far, only two known approaches have recently been developed for the site‐specific enzymatic fucosylation of oligo‐LacNAc glycans. In 2019, Boons and co‐workers reported a protecting‐group controlled site‐specific enzymatic fucosylation strategy (Scheme 1a, i), [18] in which a chemically synthesized tri‐LacNAc hexasaccharide with orthogonal protected amine groups was used as the common substrate for site‐specific enzymatic fucosylation. The lacotosamine units containing either free amine or tert ‐butyloxycarbonyl (Boc) protecting group are not tolerated by both human and bacterial α1,3‐fucosyltransferases, thus the α1,3‐fucosylation could only take place at the intact LacNAc unit [18] .…”
Section: Introductionmentioning
confidence: 99%
“…In 2019, Boons and co‐workers reported a protecting‐group controlled site‐specific enzymatic fucosylation strategy (Scheme 1a, i), [18] in which a chemically synthesized tri‐LacNAc hexasaccharide with orthogonal protected amine groups was used as the common substrate for site‐specific enzymatic fucosylation. The lacotosamine units containing either free amine or tert ‐butyloxycarbonyl (Boc) protecting group are not tolerated by both human and bacterial α1,3‐fucosyltransferases, thus the α1,3‐fucosylation could only take place at the intact LacNAc unit [18] . This protecting group controlled site‐specific fucosylation strategy nicely combined the flexibility of chemical synthesis and efficiency of enzymatic glycosylation.…”
Section: Introductionmentioning
confidence: 99%